Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-07 | The current members of the Compensation and Stock Option Committee are Dr. Stoll (Chair), Ms. Czerepak and Dr. Aharon, each of whom is "independent" within the meaning of the NASDAQ listing rules. During 2020, the Compensation and Stock Option Committee met six times. The Compensation and Stock Option Committee has a written charter, which is available on our website; go to www.delcath.com, click on "Investors," then "Corporate Governance." The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board of Directors in 2020. Gil Aharon, Ph.D. Fees Earned or Paid in Cash: $32,200 Option Awards: $226,500 Total: $258,700. |
| 2022-04-04 | Gilad Aharon, Ph.D. was appointed as a director of the Company in May 2020. Dr. Aharon is a co-founder of and has served as a Portfolio Manager at Rosalind Advisors, Inc., a life sciences-focused investment manager (Rosalind Advisors), since 2006. |
| 2024-04-12 | Gilad Aharon, Ph.D. was appointed as a director of the Company in May 2020. Dr. Aharon is a co-founder of and has served as a Portfolio Manager at Rosalind Advisors, Inc., since 2006. ... The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Stoll. ... The current members of the Compensation Committee are Mr. Sylvester (Chair), Dr. Stoll, and Dr. Aharon, each of whom is “independent” within the meaning of the Nasdaq listing rules. ... The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board in 2023. ... Gil Aharon, Ph.D. 48,000 124,956 172,956 |
| 2025-04-01 | Gilad Aharon, Ph.D. was appointed as a director of the Company in May 2020. Dr. Aharon is a co-founder of and has served as a Portfolio Manager at Rosalind Advisors, Inc., since 2006. Dr. Aharon’s financial and investment industry experience, his understanding of our business and our industry and his educational background make him extremely valuable to our Board. The current members of the Compensation Committee are Mr. Sylvester (Chair) and Dr. Aharon, each of whom is “independent” within the meaning of the Nasdaq listing rules. |
Data sourced from SEC filings. Last updated: 2025-12-06